# Irritation and Sensitization Study of d-Amphetamine Transdermal System

> **NCT04094025** · PHASE1 · COMPLETED · sponsor: **Noven Therapeutics** · enrollment: 229 (actual)

## Conditions studied

- Cumulative Irritation and Sensitization

## Interventions

- **DRUG:** dATS

## Key facts

- **NCT ID:** NCT04094025
- **Lead sponsor:** Noven Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-02
- **Primary completion:** 2020-05-16
- **Final completion:** 2020-05-16
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2020-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094025, "Irritation and Sensitization Study of d-Amphetamine Transdermal System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04094025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*